In addition, CDR1as, in contrast to its role in BC and lung adenocarcinoma, is downregulated in cisplatin-resistant ovarian cancer tissues, and it decreases the resistance of cells to cisplatin via the miR-1270/SCAI axis78. The gene discussed is LINC00632; the disease is breast cancer.